Empresa Adaptimmune Therapeutics plc
Acciones
ADAP
US00653A1079
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,19 USD | +3,48 % | +4,39 % | +50,06 % |
Resumen de negocios
Número de empleados: 449
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Cell Therapies
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +122,05 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +122,05 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 57 | 01/01/08 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01/03/15 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 01/04/20 |
Joanna Brewer
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/01/09 |
Elliot Norry
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/07/15 |
William Bertrand
COO | Chief Operating Officer | 59 | 15/03/17 |
Juli P. Miller
IRC | Investor Relations Contact | - | 01/08/16 |
Sharp Kerry
LAW | General Counsel | - | 01/10/15 |
Phil Bassett
PRN | Corporate Officer/Principal | - | - |
John Lunger
PRN | Corporate Officer/Principal | 55 | 01/03/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/11 |
Andrew Allen
BRD | Director/Board Member | 57 | 01/06/23 |
David Mott
CHM | Chairman | 58 | 01/09/14 |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01/03/15 |
Ali Behbahani
BRD | Director/Board Member | 47 | 01/09/14 |
Garry Menzel
BRD | Director/Board Member | 59 | 01/06/23 |
John Furey
BRD | Director/Board Member | 59 | 05/07/18 |
Lawrence Alleva
BRD | Director/Board Member | 74 | 01/03/15 |
Priti Hegde
BRD | Director/Board Member | 52 | 01/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 480 950 456 | 223 044 163 ( 15,06 %) | 0 | 15,06 % |
Información de la empresa
Adaptimmune Therapeutics Plc
60 Jubilee Avenue Milton Park
OX14 4RX, Abingdon
+44 12 3543 0000
http://www.adaptimmune.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+50,06 % | 304 M | |
-3,46 % | 102 mil M | |
+1,41 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-15,84 % | 21,4 mil M | |
-9,84 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-14,65 % | 16,09 mil M | |
+4,39 % | 13,83 mil M | |
+31,35 % | 11,97 mil M |
- Bolsa de valores
- Acciones
- Acción ADAP
- Empresa Adaptimmune Therapeutics plc